Definium Therapeutics DFTX
NASDAQ DFTX
$36.19 +1.10 (+3.13%)
As of: Oct 21, 2026 · 9:51 AM EDT

Definium Therapeutics (DFTX) Other financing activities (2022 - 2025)

Updated

Definium Therapeutics (DFTX) posted Other financing activities of $447,000 for FY2025, up 249.2% from $128,000 in FY2024.

Analysis

Definium Therapeutics (DFTX) Other financing activities (2022 - 2025) Analysis & Trends

Since FY2022, Definium Therapeutics has reported Other financing activities for 4 years.

  • Annual Other financing activities shows a three-year compound annual growth rate of 3.2% (FY2022 to FY2025).
  • Annual Other financing activities has run from a low of $128,000 in FY2024 to a high of $844,000 in FY2023 over five years.
  • Business Quant data shows DFTX's Other financing activities at $128,000 in FY2024 (-84.8%), $844,000 in FY2023 (+107.4%) and $407,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.84 Bn 1,106.42 Bn 19.71 Bn
2 Johnson & Johnson 618.03 Bn 536.55 Bn 17.26 Bn
3 AbbVie 507.69 Bn 480.80 Bn 12.70 Bn
4 Merck 366.91 Bn 321.28 Bn 12.21 Bn
5 Novartis Ag 298.54 Bn 262.53 Bn 11.24 Bn
6 Astrazeneca 263.16 Bn 236.84 Bn 12.86 Bn
7 Amgen 236.31 Bn 191.71 Bn 7.24 Bn
8 Gilead Sciences 192.91 Bn 167.11 Bn 6.22 Bn
9 Pfizer 171.40 Bn 118.04 Bn 10.94 Bn
10 Definium Therapeutics 4.00 Bn 1.92 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -15.95 Mn
Jun 30, 2025 -447,000.00
Sep 30, 2024 -5.28 Mn
Jun 30, 2024 -2.09 Mn
Mar 31, 2024 -8.90 Mn
Dec 31, 2023 -42,000.00
Mar 31, 2022 -407,000.00
API Access

Definium Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=DFTX&period=max&api_key=YOUR_API_KEY